British Association for Psychopharmacology (BAP) is a UK-based scientific society that promotes research and education in psychopharmacology—the study of how drugs affect mood, behaviour and mental processes. BAP supports both…
A drug used for Parkinson’s disease has been shown to be effective in reducing the symptoms of difficult to treat depression, in a study led by the University of Oxford….
Recent developments in psychiatry and neuroscience are shedding light on the potential of digital and pharmacological innovations to transform mental health care. Two new significant studies from the University of…
A new study by the University of Oxford published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in…
The successful parent-led programme, developed with support from the NIHR Oxford Health Biomedical Research Centre (OH BRC) and the Applied Research Collaboration Oxford and Thames Valley (ARC OxTV), is being…
New research has found that a mindfulness-based psychological therapy that incorporates elements from cognitive behavioural therapy (CBT), may help to reduce symptoms in people with difficult-to-treat depression (DTD). The paper,…
Statins deemed safe from a neuropsychiatric perspective but ineffective as antidepressants in at-risk adults, Oxford study finds. A landmark online trial published in Psychological Medicine and conducted at the University…
Researchers from the NIHR Mental Health Translational Research Collaboration (MH-TRC) Mission’s Children and Young People’s (CYP) Mental Health workstream have recently published a paper on brain stimulation in teenagers with Neurofibromatosis Type…
Researchers from Oxford’s two NIHR Biomedical Research Centres (BRC) took over the city’s Westgate Centre on Thursday 29 May for their annual Health Research Showcase. Hundreds of half-term visitors, including…
What happens when the last known habitat for an endangered species stands in the way of vital human development? Last Haven, a study led by researchers at the University of…
Recently, the NIHR Mental Health Translation Research Collaboration (MH-TRC) Mission Psychosis Network was launched to facilitate collaboration between psychosis researchers and clinicians in the UK. The network aims to facilitate…
Recently, children and young people’s (CYP) mental health researchers from the Children and Adolescents Data Resource (CADRE) network came together to discuss progress in building a national data platform for CYP…
The UK government has set an ambitious target to have 10% of the population participating in research by 2025. This initiative aims to enhance public engagement in scientific research, ensuring…
A major new meta-analysis has found that glucagon-like peptide 1 receptor agonists (GLP1- RAs) may also offer benefits for emotional wellbeing. A major new meta-analysis led by the Institute of…
Oxford Health Biomedical Research Centre (OH BRC) is excited to announce an academic opportunity for Nurses, Midwives, and Allied Health Professionals (NMAHPs) connected with organisations in the Buckinghamshire, Oxfordshire and…
A Joint Effort by Oxford Health BRC and the University of Oxford Department of Psychiatry. Mental Health Awareness Week is an annual event that highlights the importance of mental well-being…
Come along to our Health Research Showcase at the Westgate Centre on Thursday 29 May from 10am to learn about the broad range of healthcare research taking place in Oxford…
A new asthma study has found that a dose of inhaled beclomethasone, known as Clenil Modulite® or the ‘brown’ steroid inhaler in the UK, could lead to better clinical outcomes…
A new paper in the Journal of Neurology, Neurosurgery & Psychiatry discusses how GLP-1RAs, drugs approved for diabetes and obesity, may play a role in the treatment of major neurocognitive…
Researchers in the NIHR Mental Health Translational Research Collaboration (MH-TRC) Mental Health Mission (MHM) have contributed to a new report exploring the barriers to recruitment in mental health clinical trials…
